Carisma Therapeutics, Inc. (W2J.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 09:59AM CEST. Market open.
| Previous close | 1.5190 |
| Open | 1.4700 |
| Bid | 1.4510 x N/A |
| Ask | 1.5280 x N/A |
| Day's range | 1.4690 - 1.4700 |
| 52-week range | 1.4690 - 8.6000 |
| Volume | |
| Avg. volume | 219 |
| Market cap | 61.026M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Carisma Therapeutics Inc. (CARM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
CARISMA THERAP (CARM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Here's Why CARISMA THERAP (CARM) Is a Great 'Buy the Bottom' Stock Now
CARISMA THERAP (CARM) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
- Simply Wall St.
Individual investors account for 30% of Carisma Therapeutics, Inc.'s (NASDAQ:CARM) ownership, while institutions account for 23%
Key Insights Carisma Therapeutics' significant individual investors ownership suggests that the key decisions are...
© 2024 Yahoo. All rights reserved.